Jamil Momand
Impact in
- Oncology top 0.2%
- Cancer-related Molecular Pathways
- Biotechnology top 0.1%
- Cancer Research and Treatments
Papers in
- Oncology 28
- Cancer-related Molecular Pathways 22
- Peptidase Inhibition and Analysis 4
-
- Cancer Research and Treatments 6
- Co-authors
- Arnold J. LevineCathy A. FinlayGerard P. ZambettiDavid C. OlsonDonna L. GeorgeHsiao‐Huei WuGargi DasguptaEdward Seto
- Journals
- Gene (3 papers)Biochemical Journal (3 papers)Journal of Cellular Biochemistry (2 papers)Journal of Biological Chemistry (2 papers)Antioxidants and Redox Signaling (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Jamil Momand
40 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 6.3k
- Biotechnology 1.4k
- Cancer Research 1.6k
- Molecular Biology 6.0k
- Pathology and Forensic Medicine 756
Countries citing papers authored by Jamil Momand
This map shows the geographic impact of Jamil Momand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamil Momand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamil Momand more than expected).
Fields of papers citing papers by Jamil Momand
This network shows the impact of papers produced by Jamil Momand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamil Momand. The network helps show where Jamil Momand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jamil Momand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 14 | |
| 2 | 2018 | 19 | |
| 3 | 2017 | 40 | |
| 4 | 2017 | 8 | |
| 5 | 2017 | 2 | |
| 6 | 2017 | 7 | |
| 7 | 2015 | 5 | |
| 8 | 2013 | 70 | |
| 9 | 2011 | 42 | |
| 10 | 2006 | 123 | |
| 11 | 2002 | 41 | |
| 12 | MDM2 — master regulator of the p53 tumor suppressor protein Hit paper breakdown → | 2000 | 519 |
| 13 | 2000 | 63 | |
| 14 | The MDM2 gene amplification database Hit paper breakdown → | 1998 | 792 |
| 15 | 1997 | 35 | |
| 16 | 1997 | 70 | |
| 17 | 1996 | 99 | |
| 18 | The p53 tumour suppressor gene Hit paper breakdown → | 1991 | 3311 |
| 19 | 1991 | 8 | |
| 20 | 1990 | 7 |
About Jamil Momand
Jamil Momand is a scholar working on Oncology, Biotechnology, Molecular Biology, Biochemistry and Cancer Research, having authored 40 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (22 papers), Cancer Research and Treatments (6 papers), RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (5 papers), Peptidase Inhibition and Analysis (4 papers), RNA Research and Splicing (4 papers), Folate and B Vitamins Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (6.3k citations), Biotechnology (1.4k citations), Cancer Research (1.6k citations), Molecular Biology (6.0k citations) and Pathology and Forensic Medicine (756 citations). Jamil Momand has collaborated with scholars based in United States, China and France. Frequent co-authors include Arnold J. Levine, Cathy A. Finlay, Gerard P. Zambetti, David C. Olson, Donna L. George, Hsiao‐Huei Wu, Gargi Dasgupta, Edward Seto, Roberto Weinmann and Thomas Shenk. Their work appears in journals such as Gene, Biochemical Journal, Journal of Cellular Biochemistry, Journal of Biological Chemistry and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.